{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:28Z","timestamp":1759048228035},"reference-count":29,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1034\/j.1600-0404.2001.103003180.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T02:26:30Z","timestamp":1047349590000},"page":"180-187","source":"Crossref","is-referenced-by-count":12,"title":["Anti-GM1 and anti-sulfatide antibodies in polyneuropathies\u2028Threshold titers and accuracy"],"prefix":"10.1155","volume":"103","author":[{"given":"G.","family":"Isoardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oggero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pipieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verdun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bergamasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Durelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1034\/j.1600-0404.2001.103003180.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":":209","DOI":"10.1054\/jocn.1999.0217","article-title":"Results of testing for anti-GM1 antibodies","volume":"7","author":"McCombe","year":"2000","journal-title":"J Clin Neurosci"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mus.880170115","article-title":"The clinical and diagnostic role of anti-GM1 antibody testing","volume":"17","author":"Kornberg","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/ana.410370706","article-title":"Chronic motor neuropathies: diagnosis, therapy and pathogenesis","volume":"37 (suppl 1)","author":"Kornberg","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.47.4.951","article-title":"The sensitivity and specificity of anti-GM1 antibody testing","volume":"47","author":"Taylor","year":"1996","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB6|cit7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","article-title":"Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies","volume":"27","author":"Pestronk","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1212\/WNL.53.9.2206","article-title":"Margin-ally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy","volume":"53","author":"Carpo","year":"1999","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410350217","article-title":"The clinical correlates of high-titer IgG anti-GM1 antibodies","volume":"35","author":"Kornberg","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.41.3.357","article-title":"Poly-neuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein","volume":"41","author":"Pestronk","year":"1991","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0022-510X(92)90145-B","article-title":"Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons","volume":"112","author":"Quattrini","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB13|cit14","first-page":"79","article-title":"Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy","volume":"43","author":"Nemni","year":"1993","journal-title":"J Neuro-immunol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB14|cit15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp.56.11.1164","article-title":"Anti-sulfatide antibodies in peripheral neuropathy","volume":"56","author":"Van Den Berg","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.62.6.581","article-title":"Polyneuropathies associated with high titre anti-sulfatide antibodies: characteristics of patients with and without serum monoclonal proteins","volume":"62","author":"Lopate","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB16|cit17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.54.7.1448","article-title":"Anti-sulfatide antibodies in neuropathy. Clinical and electrophysiological correlate","volume":"54","author":"Dabby","year":"2000","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB18|cit19","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 (suppl)","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB19|cit20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","author":"Cornblath","year":"1991","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB20|cit21","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.410370705","article-title":"Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies","volume":"37 (suppl 1)","author":"Latov","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB21|cit22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1528-1157.1996.tb00527.x","article-title":"Cryptogenetic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?","volume":"37","author":"Bartolomei","year":"1996","journal-title":"Epilepsia"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB22|cit23","first-page":"13","article-title":"The use of relative operating charac-teristic (ROC) curves in test performance evaluation","volume":"110","author":"Beck","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB23|cit24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB24|cit25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jnnp.56.10.1066","article-title":"Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients","volume":"56","author":"Notermans","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB25|cit26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/(sici)1097-4598(199710)20:10<1275::aid-mus10>3.3.co;2-d","article-title":"Antibody panels in idiopathic polyneuropathy and motor neuron disease","volume":"20","author":"Wolfe","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB26|cit27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1212\/WNL.53.9.1905","article-title":"To test or not to test? That is the question","volume":"53","author":"Holloway","year":"1999","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB27|cit28","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1212\/WNL.54.12.2353","article-title":"Testing for serum IgM binding to GM1 ganglioside in clinical practice","volume":"54","author":"Pestronk","year":"2000","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB28|cit29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.45.8.1570","article-title":"Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis","volume":"45","author":"Van Schaik","year":"1995","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2001.103003180.x-BIB29|cit30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/(sici)1097-4598(199801)21:1<55::aid-mus8>3.0.co;2-f","article-title":"Peripheral neuropathy associated with IgM mono-clonal gammopathy: correlations between M-protein antibody activity and clinical\/electrophysiological features in 40 cases","volume":"21","author":"Chassande","year":"1998","journal-title":"Muscle Nerve"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2001.103003180.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2001.103003180.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-0404.2001.103003180.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:43:19Z","timestamp":1671540199000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-0404.2001.103003180.x"}},"subtitle":["Anti-GM1 and anti-sulfatide Ab in neuropathy"],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-0404.2001.103003180.x","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}